We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
New maximum single intravenous dose of ondansetron for the management of chemotherapy-induced nausea and vomiting (CINV) restricted due to risk of QTc prolongation.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
You may need to tell DVLA if you have cancer - if you do, download the correct form to let them know
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
The symptoms, diagnosis, management, surveillance and epidemiology of salmonella.
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
Urgent public health message: UKHSA has been notified about an outbreak of food botulism in France involving a small number of British nationals.
Population-based statistics on cancers treated with chemotherapy, radiotherapy and surgical tumour resection which were diagnosed between 2013 and 2016 in England.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
A companion report to the Lancet Oncology paper, providing trust-level analyses.
Find out about the long-term effects some people can have after having COVID-19.
Information on cryptosporidium including sources and routes of transmission, symptoms, and general hygiene advice to minimise the spread.
Restricted dose and duration of use.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.